Dishman Carbogen Amcis Ltd updates on USFDA inspection at its Bavla facility

The USFDA inspection planned between 4th March, 2024 to 8th March, 2024 at the Dishman Carbogen Amcis Limited's facility in Bavla, Ahmedabad, was successfully completed on 7th March, 2024.

The inspection was concluded with few procedural observations and the same will be addressed within the stipulated timelines.

No any serious issue was raised during the course for the entire inspection.

Thus, the Company's facilities in Bavla and Naroda in India, multiple facilities in Switzerland and the Netherlands continue to be approved by the US FDA.

Shares of Dishman Carbogen Amcis Limited was last trading in BSE at Rs. 247.15 as compared to the previous close of Rs. 242.40. The total number of shares traded during the day was 38534 in over 1246 trades.

The stock hit an intraday high of Rs. 253.70 and intraday low of 243.25. The net turnover during the day was Rs. 9547487.00.

Source : Equity Bulls

Keywords

DishmanCarbogenAmcis INE385W01011 USFDAInspection Update BavlaFacility